Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 129Colonic Neoplasms 54Rectal Neoplasms 48Carcinoma, Hepatocellular 29Stomach Neoplasms 23Neoplasm Metastasis 23Neoplasms 11Pancreatic Neoplasms 10Cholangiocarcinoma 9Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Liver Neoplasms 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Recurrence 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Unresectable Metastatic Colorectal Cancer 2Peritoneal Neoplasms 2Neurotoxicity Syndromes 2Neoplastic Cells, Circulating 2Intestinal Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2

Interventions

pembrolizumab 1pamiparib 1famitinib 1enzalutamide 1apalutamide 1abiraterone 1Prednisone 1Prednisolone 1Poly(ADP-ribose) Polymerase Inhibitors 1Neoadjuvant Therapy 1Folfox protocol 1Fluorouracil 1Drug Therapy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoadjuvant Therapy × Folfox protocol × Clear all
NCT05352165 2022-04-28

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

Shanghai Minimally Invasive Surgery Center

Phase NA Unknown
192 enrolled

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡